Pharmaceutical Chemistry Journal

, Volume 33, Issue 4, pp 177–187 | Cite as

Some approaches to the directed search for new drugs based on nicotinic acid

  • V. M. Kopelevich
  • V. I. Gunar
Search for New Drugs

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    V. A. Yakovlev, V. G. Kukes, and V. M. Avakumov,Clinical Pharmacology [in Russian], Meditsina, Moscow (1978), p. 323.Google Scholar
  2. 2.
    V. V. Vinogradov,Noncoenzyme Functions of Vitamin PP [in Russian], Nauka i Tekhnika, Minsk (1987).Google Scholar
  3. 3.
    V. A. Yakovlev (ed.),Coenzymes [in Russian], Meditsina, Moscow (1983), p. 13.Google Scholar
  4. 4.
    N. M. Leutskii,Nicotinic Acid [in Russian], Lvov University, Lvov (1972).Google Scholar
  5. 5.
    D. Dolphin (ed.),Coenzymes and Cofactors. Pyridine Nucleotide Coenzymes: Chemical and Medical Aspects, Wiley, New York (1987), Vol. 2.Google Scholar
  6. 6.
    K. F. Gey and L. A. Carlson (eds.),Metabolic Effects of Nicotinic Acid and Its Derivaties, Huber, Bern (1971).Google Scholar
  7. 7.
    G. Ya. Sidoruk,Author's Abstract of Cand. Sci. (Med.) Thesis [in Russian], Odessa (1967).Google Scholar
  8. 8.
    Belgium Patent No. 558 779;Ref. Zh. Khim., 10L 383 (1961).Google Scholar
  9. 9.
    H. Backer,Br. J. Dermatol.,81, 60–62 (1969).CrossRefGoogle Scholar
  10. 10.
    UK Patent Application No. 2 184 652; European Patent No. 220 825;Chem. Abstr.,107, 161697a (1987).Google Scholar
  11. 11.
    French Patent Application No. 2 509 301;Ref. Zh. Khim., 230 35P (1984).Google Scholar
  12. 12.
    R. Brattsand and L. Harthon,Arzneim.-Forsch.,21, 1335–1338 (1971).Google Scholar
  13. 13.
    L. Harthon, and R. Brattsand,Arzneim.-Forsch.,29, 1859–1864 (1979).Google Scholar
  14. 14.
    H. Salmi and H. Frey,Curr. Therap. Res.,16, 669–671 (1974).Google Scholar
  15. 15.
    P. Abogaro, G. Bittolo-Bon., and G. Gazzolato,Pharmacol. Res. Commun.,10, 127–128 (1978).CrossRefGoogle Scholar
  16. 16.
    L. Puglisi, F. Maggi., S. Colli, et al.,Pharmacol. Res. Commun.,11, 775–776 (1979).PubMedCrossRefGoogle Scholar
  17. 17.
    A. Subissi, M. Biagi, and W. Murmann,Arznein.-Forsch.,30, 1278–1283 (1980).Google Scholar
  18. 18.
    L. Harthon and K. Sigroth,Arzneim.-Forsch.,34, 1688–1692 (1984).Google Scholar
  19. 19.
    V. Kopelevich, I. Gracheva, E. Orekhova, et al.,Proc. 14th Intern. Congr. Heterocyclic Chemistry, Antwerp (1993), pp. PO1–PO3.Google Scholar
  20. 20.
    I. N. Gracheva, E. M. Orekhova, B. A. Kleshchitskii, et al.,Khim.-Farm. Zh.,27(3), 24–29 (1993).Google Scholar
  21. 21.
    I. N. Gracheva, E. M. Orekhova, V. M. Kopelevich, et al.,Khim.-Farm. Zh.,30(7), 27–30 (1996).Google Scholar
  22. 22.
    A. Olson, L. Oro, and S. Rossner,Atherosclerosis,19, 61–73 (1974).CrossRefGoogle Scholar
  23. 23.
    E. Garrett and M. Gardner,J. Pharm. Sci.,71, 14–19 (1982).PubMedGoogle Scholar
  24. 24.
    H. Oelschlager, D. Rothley, M. Ewert, et al.,Arzneim.-Forsch.,30, 984–990 (1980).Google Scholar
  25. 25.
    French Patent No. 2 341 310;Chem. Abstr.,89, 75350 (1978).Google Scholar
  26. 26.
    E. Marmo, A. Imperatore, A. Caputi, et al.,Farmaco Prat.,26, 557–564 (1971).PubMedGoogle Scholar
  27. 27.
    M. Cohen,Life Sci.,21, 1949–1961 (1985).CrossRefGoogle Scholar
  28. 28.
    K. Aktories, G. Schultz, and K. Jakobs,Arzneim.-Forsch.,33, 1525–1527 (1983).Google Scholar
  29. 29.
    M. N. Coyen,Drug. Metab. Rev.,11, 291–323 (1980).Google Scholar
  30. 30.
    A. Kuzi, T. Nakomura, S. Kato, et al.,Jpn. J. Pharmacol.,27, 817–821 (1977).Google Scholar
  31. 31.
    A. P. Caputi,Res. Med. Sper.,22, 134–169 (1975).Google Scholar
  32. 32.
    S. Rimondi, G. Descovich, and S. Lenzi,Abstracts of Papers. Int. symp. Drug Affect. Lipid Metab., Milan (1978), p. 180.Google Scholar
  33. 33.
    Japan Patent No. 18 109 (1965).Google Scholar
  34. 34.
    US Patent No. 4 288 441;Chem. Abstr.,96, 6598e (1982).Google Scholar
  35. 35.
    Swiss Patent No. 661 435;Ref. Zh. Khim., 21O 41P (1991).Google Scholar
  36. 36.
    A. G. Moiseenok, V. M. Kopelevich, V. M. Sheibak, and V. A. Gurinovich,Pantothenic Acid Derivatives [in Russian], Nauka i Tekhnika, Minsk (1989), pp. 175–182.Google Scholar
  37. 37.
    Japan Patent Application No. 30 877 (1975);Ref. Zh. Khim., 14O 147P (1977).Google Scholar
  38. 38.
    S. Nobozu and N. Tetsuya,J. Nutr. Sci. Vitaminol.,29 93–103 (1983).Google Scholar
  39. 39.
    Japan Patent Application No. 197 284 (1982);Ref. Zh. Khim., 15O, 175P (1984).Google Scholar
  40. 40.
    Japan Patent Application No. 225 184 (1981);Ref. Zh. Khim., 3O 1125P (1986).Google Scholar
  41. 41.
    French Patent No. 1 518 970;Chem. Abstr. 71, 30365 f (1969).Google Scholar
  42. 42.
    Japan Patent Application No. 21 959 (1973);Ref. Zh. Khim. 12N 372 P (1974).Google Scholar
  43. 43.
    B. S. Naumova, I. B. Chekmareva, E. S. Zhdanvich, and N. A. Preobrazhenskii,Khim.-Farm. Zh.,3(5), 11–12 (1969).Google Scholar
  44. 44.
    K. Toshio,Vitamin,39, 221–227 (1969).Google Scholar
  45. 45.
    V. I. Koltunova and V. M. Berezovskii,Vitamins and Vitamin Preparations [in Russian], Meditsina, Moscow (1973), pp. 6–41.Google Scholar
  46. 46.
    Swiss Patent No. 555 337;Ref. Zh. Khim., 10O 168P (1975).Google Scholar
  47. 47.
    P. Mantovani,Bull. Soc. Ital. Biol. Sper.,48, 1274–1278 (1972).Google Scholar
  48. 48.
    J. Bremer,Physiol. Rev.,63, 1421–1480 (1080).Google Scholar
  49. 49.
    V. M. Avvakumov, I. V. Klement'eva, and I. V. Smirnova,Khim.-Farm. Zh.,22(3), 379–382 (1988).Google Scholar
  50. 50.
    UK Patent No. 1 496 625;Ref. Zh. Khim 15O 115P (1978).Google Scholar
  51. 51.
    I. B. Chekmareva, E. S. Zhadanovich, T. S. Novopokrovskaya, and N. A. Preobrazhenskii,Zh. Prikl. Khim.,35, 1157–1159. (1962).Google Scholar
  52. 52.
    Romanian Patent No. 82 644;Ref. Zh. Khim., 23O 87P (1985).Google Scholar
  53. 53.
    E. I. Levkoeva, L. I. Mastafanova, D. M. Krasnokutskaya, et al.,Khim. Geterotskikl. Soedin, No. 2, 233–237 (1976).Google Scholar
  54. 54.
    Ya. S. Karpman and L. N. Yakhontov,Khim.-Farm. Zh.,14(3), 93–96 (1980).Google Scholar
  55. 55.
    V. I. Trubnikov,Author's Abstract of Cand. Sci. (Tech.) Thesis [in Russian], Moscow (1969).Google Scholar
  56. 56.
    P. Barczynski,Rocz. Chem.,48, 903–907 (1974).Google Scholar
  57. 57.
    Japan Patent Application No. 30 877 (1975);Ref. Zh. Khim., 14O 147P (1977).Google Scholar
  58. 58.
    Japan Patent, Application No. 6967 (1978);Chem. Abstr.,85, 108826 (1976).Google Scholar
  59. 59.
    Swiss Patent No. 551 414;Ref. Zh. Khim. 14O 147P (1977).Google Scholar
  60. 60.
    Japan Patent Application No. 144 638 (1978);Chem. Abstr.,89, 24827 (1978).Google Scholar
  61. 61.
    B. Wintgersteiger,Arch. Pharm.,315, 946–949 (1982).Google Scholar
  62. 62.
    K. Furakawa, T. Itoh, M. Hajiwara, et al.,Pharmacol. Exp. Therap.,218 248–259 (1981).Google Scholar
  63. 63.
    D. Tadahiko, D. Shuji, I. Hiroki, et al.,Stroke (Dallas),25, 1644–1650 (1990).Google Scholar
  64. 64.
    I. M. Ryaposova, I. S. Severina, and V. M. Kopelevich,Khim.-Farm. Zh.,31(8) 5–6 (1997).Google Scholar
  65. 65.
    A. Frydman, P. Chapelle, H. Diekman et al.,Am. J. Cardiol.,63, 25j-33j (1989).PubMedCrossRefGoogle Scholar
  66. 66.
    SCRIP, No. 1972, 25 (1995).Google Scholar
  67. 67.
    M. Knumenacker and E. Roland,Cardiovasc. Pharmacol.,20, 93–102 (1992).Google Scholar
  68. 68.
    US Patent No. 4 021 436;Ref. Zh. Khim., 3O 105P (1978).Google Scholar
  69. 69.
    US Patent, No. 3 961 064;Ref. Zh. Khim., 2O 103P (1977).Google Scholar
  70. 70.
    T. Fujita,J. Label. Compounds,9, 159–160 (1973).Google Scholar
  71. 71.
    T. Fujita,J. Label. Compounds 9, 553–554 (1973).Google Scholar
  72. 72.
    V. M. Kopelevich,Usp. Khim.,48, 1273–1296 (1979).Google Scholar
  73. 73.
    USSR Inventor's Certificate No. 325 232;Byull. Izobret., No. 3 (1972).Google Scholar
  74. 74.
    A. Ya. Rozanov, V. I. Gunar, V. M. Kopelevich, et al., In:Picamilon—A New Cebrovascular and Nootropic Drug [in Russian], VNIISENTI, Moscow (1989), pp. 126–135.Google Scholar
  75. 75.
    R. S. Mirzoyan and V. M. Kopelevich, (eds.),Picamilon—A New Cebrovascular and Nootropic Drug [in Russian], VNIISENTI, Moscow (1989).Google Scholar
  76. 76.
    V. M. Kopelevich and M. A. Kovler (eds.),Picamilon in the Current Neurological and Psychiatric Practice [in Russian], Moscow (1994).Google Scholar
  77. 77.
    V. M. Kopelevich, L. N. Bulanova, and V. I. Gunar, in:Picamilon—A New Cebrovascular and Nootropic Drug [in Russian], VNIISENTI, Moscow (1989) pp. 5–14.Google Scholar
  78. 78.
    G. I. Kuz'menko, L. E. Gotsulyakh, A. I. Gaidenko, et al.,Farmakol. Toksikol., No. 1, 12–14 (1980).Google Scholar
  79. 79.
    V. M. Kopelevich, L. N. Bulanova, I. A. Grigor'ev, et al.,Khim.-Farm. Zh.,31, (10), 30–33 (1997).Google Scholar
  80. 80.
    E. A. Kuznetsova, T. A. Voronina, I. V. Khromova, et al.,Khim.-Farm. Zh.,23(12), 1425–1431 (1989).Google Scholar
  81. 81.
    USSR Inventor's Certificate No. 1 368 314;Byull. Izobret., No. 3 (1988).Google Scholar
  82. 82.
    S. V. Krapivina, T. A. Voronina, and N. N. Bogdanov,Khim.-Farm. Zh.,28(4), 11–15 (1994).Google Scholar
  83. 83.
    T. L. Garibova, T. A. Voronina, V. V. Kraineva, et al.,Abstracts of Papers. The 6th All-Russia Congr. “Mankind and Drugs”, [in Russian], Farmedinfo, Moscow (1996), p. 97.Google Scholar
  84. 84.
    O. I. Aliev,Abstracts of Papers. The 1st Congr. Russian Sci. Soc. Pharmacists [in Russian], Moscow (1995), p. 16.Google Scholar
  85. 85.
    Ya. B. Maksimovich, N. G. Antipov, and B. V. Grechko,Physiology and Pathology of Digestion [in Rissian], Shtiintsa, Kishinev (1972), pp. 165–166.Google Scholar
  86. 86.
    V. M. Demidov,Author's Abstract of Cand. Sci. (Med.) Thesis [in Russian], Moscow (1980).Google Scholar
  87. 87.
    FRG German Patent No. 2 200 589;Ref. Zh. Khim., 13O 119P (1978).Google Scholar
  88. 88.
    UK. Patent No. 1 408 481Google Scholar
  89. 89.
    H. Meyer and R. Graf,Biochem. Z.,229, 154 (1930).Google Scholar
  90. 90.
    G. I. Kovalev, V. M. Kopelevich, L. N. Bulanova, et al.,Khim.-Farm. Zh.,13, (10), 18–22 (1979).Google Scholar
  91. 91.
    L. A. Zhmurenko, S. A. Borizenko, O. M. Glozman, et al.,Khim.-Farm. Zh.,14(9), 49–55 (1980).Google Scholar
  92. 92.
    K. Prasad, B. Jyer, and M. Sizsi,J. Ind. Chem. Soc.,42, 10–14. (1965).Google Scholar
  93. 93.
    M. Wu and R. LyleJ. Pharm. Sci.,61, 477–478 (1972).PubMedGoogle Scholar
  94. 94.
    K. Matsuyama, C. Yamashita, A. Noda et al.,Chem. Pharm. Bull.,32, 4089–1095 (1984).PubMedGoogle Scholar
  95. 95.
    French Patent No. 1 451 176;Chem. Abstr.,66, 115951 (1967).Google Scholar
  96. 96.
    M. Wu and R. LyleJ. Pharm. Sci.,61, 141–142 (1972).PubMedGoogle Scholar
  97. 97.
    Sh. Tu and M. Zhuang,Zhongguo Yiyao Gongye Zazhi,24(11), 483–484 (1993);Chem. Abstr.,121, 82983 (1994).Google Scholar
  98. 98.
    M. Schou,Nervenarzt,42, 1–10 (1971).PubMedGoogle Scholar
  99. 99.
    V. I. Kresyun and Ya. B. Maksimovich,Vrachebn. Delo, No. 8, 99–101 (1973).Google Scholar
  100. 100.
    V. A. Aryaev,Abstracts of Papers. The 5th All-Union Meet. Pharmacists [in Russia], Yerevan (1982), p. 27.Google Scholar
  101. 101.
    B. I. Lyubimov, N. S. Tolmacheva, R.Kh. Ostrovskaya, et al.,Farmakol. Toksikol., No. 3, 273–277 (1980).Google Scholar
  102. 102.
    L. B. Aksel'rod, L. S. Arshinova, O. I. Bogun, et al.,Abstracts of Papers. The All-Union Symp. Directed Search for New Physiologically Active Substances [in Russian], Riga (1979), p. 70.Google Scholar
  103. 103.
    S. S. Rybalova,Author's Abstract of Cand. Sci. (Med.) Thesis [in Russian], Odessa (1975).Google Scholar
  104. 104.
    French Patent Application No. 2 409 754;Ref. Zh Khim., 17O 85P (1980).Google Scholar
  105. 105.
    M. D. Mashkovskii and S. D. Yuzhakov,Klin. Med., No. 11, 30–34 (1984).Google Scholar
  106. 106.
    A. D. Kazanov,Author's Abstract of Cand. Sci. (Med.) Thesis [in Russian], Odessa (1975).Google Scholar
  107. 107.
    N. Bodor, H. Farag, and M. Brewster,Science,214, 1370–1372 (1981).PubMedCrossRefGoogle Scholar
  108. 108.
    N. Bodor,Drugs Future,6, 165–182 (1981).Google Scholar
  109. 109.
    N. Bodor and H. Farag,J. Med. Chem.,26, 213–219 (1983).Google Scholar
  110. 110.
    N. Bodor and M. Brewster,Pharmacol. Therap.,19, 337–386 (1983).CrossRefGoogle Scholar
  111. 111.
    US Patent No. 4 479 932; Baelgium Patent No. 889 563;Chem. Abstr.,97, 665 In (1982).Google Scholar
  112. 112.
    B. Navia, B. Jordasn, and R. Price,Ann. Neurol.,19, 517–524, (1986).PubMedCrossRefGoogle Scholar
  113. 113.
    A. Fanci,Science,239 617–622 (1988).Google Scholar
  114. 114.
    P. Torrence, J. Kinjo, K. Lesiak et al.,FEBS Lett.,234, 135–140 (1988).PubMedCrossRefGoogle Scholar
  115. 115.
    E. Palomino, D. Kessel, and J. Horwitz,J. Med. Chem.,32, 625–629 (1989).CrossRefGoogle Scholar
  116. 116.
    E. Palomino, D. Kessel, and J. Horwitz,Nucleosides Nucleotides,11, 1639–1649 (1989).Google Scholar
  117. 117.
    A. Miyake and N. Bodor,Pharm. Sci. Commun.,4, 231–237 (1994).Google Scholar

Copyright information

© Kluwer Academic/Plenum Publishers 1999

Authors and Affiliations

  • V. M. Kopelevich
    • 1
  • V. I. Gunar
    • 1
  1. 1.“Vitaminy” Research and Production CorporationMoscowRussia

Personalised recommendations